Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1582 of 6351
-
Could virtual reality help kids with brain disorders learn and move better?
Symptom relief Recruiting nowNeurodevelopmental disorders, such as Cerebral Palsy (CP), Attention-Deficit/Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), are complex conditions that affect various aspects of children's development. Despite advancements in treatments, conventional rehabilitativ…
Sponsor: IRCCS Centro Neurolesi Bonino Pulejo • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New hope for amputees: nerve surgery may ease phantom limb pain
Symptom relief Recruiting nowRationale: Postamputation pain (PAP) is frequently seen after amputations and is a severe lifelong disabling condition affecting quality of life (QoL). Different nerve surgical techniques are available to treat PAP if non-surgical treatment options are not sufficient. Multiple te…
Sponsor: Leiden University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Pre-surgery boot camp may boost recovery for frail cancer patients
Disease control Recruiting nowIn this 2-arm, non-randomized, phase II trial, the investigators will evaluate the efficacy and safety of comprehensive multimodal prehabilitation (CMMP) alone or in combination with planned neoadjuvant (NAT) in pre-frail/frail patients with probable/proven pancreaticobiliary, ov…
Phase 2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New study offers free STI care to black youth in the deep south
Disease control Recruiting nowThis study includes testing for four STIs (chlamydia, gonorrhea, syphilis, and HIV) at no cost. If positive, individual subjects will also be counseled and offered options for treatment for themselves and their sex partners that may include no cost expedited treatment and the opt…
Sponsor: Tulane University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New hope for Crohn's? experimental antibody BCD-261 enters Mid-Stage trial
Disease control Recruiting nowThe aim of the study is to evaluate the efficacy, safety, pharmacokinetics, pharmacodynamics and immunogenicity of study drug (BCD-261) in comparison with placebo and to characterize the dose-response relationship in patients with moderate to severe active Crohn's Disease. The st…
Phase 2 • Sponsor: Biocad • Aim: Disease control
Last updated Jun 26, 2026 18:16 UTC
-
Radiation boost may help control advanced pancreatic cancer
Disease control Recruiting nowThis is a Phase II, multicenter, randomized controlled trial to assess the efficacy of Stereotactic Body Radiotherapy (SBRT) in combination with maintenance therapy in patients with advanced pancreatic cancer. The aim is to compare the efficacy of SBRT combined with maintenance t…
Phase 2 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for early Alzheimer's? drug GSK4527226 tested for Long-Term safety
Disease control Recruiting nowThe study medicine GSK4527226 is being studied in participants with Alzheimer's Disease (AD) in study 219867 (the parent study, NCT06079190). This new study is an extension of that parent study called an open-label extension (OLE). An OLE is a clinical trial where all participant…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New antibody drug shows promise for tough ulcerative colitis cases
Disease control Recruiting nowThe aim of the study is to evaluate the efficacy, safety, pharmacokinetics, pharmacodynamics and immunogenicity of study drug (BCD-261) in comparison with placebo and to characterize the dose-response relationship in patients with moderate to severe active ulcerative colitis. The…
Phase 2 • Sponsor: Biocad • Aim: Disease control
Last updated Jun 26, 2026 18:48 UTC
-
New epilepsy drug shows promise in Long-Term safety trial
Disease control Recruiting nowCB03-154 is an investigational drug developed by Shanghai Zhimeng Biopharma Inc. for the treatment of Focal Epilepsy.
Phase 2 • Sponsor: Shanghai Zhimeng Biopharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Phone-based program aims to get seniors moving and reduce arthritis pain
Symptom relief Recruiting nowThe experience of chronic pain powerfully and negatively affects quality of life and functional independence in aging. Unfortunately, while as many as three in four older adults experience chronic pain, few have access to effective non-pharmacological pain management strategies. …
Phase 2 • Sponsor: Wake Forest University • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
New drug cocktail targets Hard-to-Treat brain lymphoma
Disease control Recruiting nowThe purpose of this study is to find out whether the combination of epcoritamab and ibrutinib is a safe treatment approach that causes few or mild side effects in people with relapsed/refractory primary central nervous system lymphoma (PCNSL) or secondary central nervous system l…
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could a simple Self-Swab replace the pap smear? indonesia tests HPV Self-Collection
Diagnosis By invitation onlyThe purpose of this study is to implement human papillomavirus (HPV) self-collection in Indonesia.
Sponsor: Dharmais National Cancer Center Hospital • Aim: Diagnosis
Last updated Jun 26, 2026 18:07 UTC
-
Experimental cocktail aims to outsmart Hard-to-Treat breast cancer
Disease control Recruiting nowThe goal of this clinical research study is to find the best dose of the drugs cyclophosphamide and axatilimab that can be given in combination with the standard dose of retifanlimab to patients with metastatic TNBC.
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New IVIg therapy aims to boost platelets in chronic ITP patients
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of KIg 10 (Intravenous Immunoglobulin 10%) in adult patients with chronic primary ITP
Phase 3 • Sponsor: Kedrion S.p.A. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Experimental cell therapy takes on lupus and other autoimmune diseases
Disease control Recruiting nowThis study evaluates the safety and efficacy of YTS109 cells in adults with relapsed/refractory autoimmune diseases, such as Systemic Lupus Erythematosus (SLE), including LN and SLE-ITP, Sjogren's Syndrome, etc. Aproximately 18 patients aged 18-65 will receive a single infusion o…
Phase 1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Neck fracture showdown: surgery or brace for seniors?
Disease control Recruiting nowThe goal of this clinical trial is to compare two treatment options-surgery or rigid collar bracing-for unstable neck fractures (odontoid fractures) in adults aged 70 years and older. These fractures are common in older adults and can significantly impact mobility, independence, …
Sponsor: Technical University of Munich • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug aims to reduce Blood-Letting in rare blood cancer
Disease control OngoingThis open-label, multicenter, within-participant dose escalation study examining up to 2 dose levels of DISC-3405 will assess the safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of DISC-3405 in participants with polycythemia vera (PV).
Phase 2 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a smartphone app lift depression in cancer survivors?
Symptom relief Recruiting nowThe purpose of this research study is to evaluate different depression treatment approaches among cancer survivors. A cancer survivor is defined as anyone who is living and has been diagnosed with cancer. Participants will be randomly assigned to either receive a mobile app for …
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Which filling base lasts longest? a Head-to-Head test
Disease control By invitation onlyThis randomized controlled clinical trial is designed to clinically evaluate and compare the performance of five dentin replacement materials used beneath posterior composite restorations.
Sponsor: Tanta University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a gel stop bleeding after prostate surgery and send men home the same day?
Disease control Recruiting nowRandomized, single-blinded investigational study to assess the safety of PuraStat following the Aquablation procedure
Sponsor: Endeavor Health • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC